Patents by Inventor Andrew W. Han

Andrew W. Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS
    Publication number: 20240076323
    Abstract: The disclosure relates to therapeutic proteins and pharmaceutical compositions comprising said proteins, which have utility in treating various human diseases. In particular aspects, the disclosed therapeutic proteins are useful for treating human gastrointestinal inflammatory diseases and gastrointestinal conditions associated with decreased epithelial cell barrier function or integrity. Further, the disclosed therapeutic proteins are useful for treating human inflammatory bowel disease, including inter alia, Crohn's disease and ulcerative colitis.
    Type: Application
    Filed: July 18, 2023
    Publication date: March 7, 2024
    Inventors: Andrew Wonhee Han, Andrew W. Goodyear, Tarunmeet Gujral, Todd Zachary DeSantis, Karim Dabbagh
  • Proteins for the treatment of epithelial barrier function disorders
    Patent number: 11505583
    Abstract: The disclosure relates to therapeutic proteins and pharmaceutical compositions comprising said proteins, which have utility in treating various human diseases. In particular aspects, the disclosed therapeutic proteins are useful for treating human gastrointestinal inflammatory diseases and gastrointestinal conditions associated with decreased epithelial cell barrier function or integrity. Further, the disclosed therapeutic proteins are useful for treating human inflammatory bowel disease, including inter alia, Crohn's disease and ulcerative colitis.
    Type: Grant
    Filed: April 8, 2019
    Date of Patent: November 22, 2022
    Assignee: Second Genome, Inc.
    Inventors: Cristina N. Butterfield, Daniela Keilberg, Andrew W. Goodyear, Andrew W. Han
  • MICROBIALLY DERIVED PEPTIDES AND PROTEINS FOR IMMUNOTHERAPY
    Publication number: 20220089653
    Abstract: The disclosure provides therapeutic peptides and pharmaceutical compositions comprising the peptides, which have utility in treating various human diseases. In particular aspects, the disclosed therapeutic peptides are useful as immunotherapeutics for modulating regulatory and effector molecules of the mammalian immune system to mitigate disease.
    Type: Application
    Filed: January 6, 2020
    Publication date: March 24, 2022
    Inventors: Yuliya Katlinskaya, Helena Kiefel, Kareem L. Graham, Todd Z. DeSantis, Sunit Jain, Andrew W. Han, Karim Dabbagh
  • Proteins for the Treatment of Epithelial Barrier Function Disorders
    Publication number: 20210230236
    Abstract: The disclosure relates to therapeutic proteins and pharmaceutical compositions comprising said proteins, which have utility in treating various human diseases. In particular aspects, the disclosed therapeutic proteins are useful for treating human gastrointestinal inflammatory diseases and gastrointestinal conditions associated with decreased epithelial cell barrier function or integrity. Further, the disclosed therapeutic proteins are useful for treating human inflammatory bowel disease, including inter alia, Crohn's disease and ulcerative colitis.
    Type: Application
    Filed: April 8, 2019
    Publication date: July 29, 2021
    Inventors: Cristina N. Butterfield, Daniela Keilberg, Andrew W. Goodyear, Andrew W. Han